Human genetic studies in the past two decades have demonstrated that FSGS is primarily a podocytopathy with more than 20 mutated podocyte genes confidently implicated in the pathogenesis of NS/FSGS [
14]. These mutated genes can be divided into the following categories: (a) SD-associated molecules, (b) podocyte cytoskeleton related molecules, (c) podocyte transcription factors, and (d) adhesion and extracellular matrix molecules. (a) SD-associated molecules include nephrin, podocin [
15], CD2AP, and transient receptor potential cation channel 6 (
TRPC6). Mutated
NPHS1 was the first podocyte gene identified in congenital NS (CNS) of the Finnish type [
16]. This discovery revolutionized our understanding of the pathogenesis of NS/FSGS. CD2AP is a 70 KD adaptor/linker protein involved in regulation of the actin cytoskeleton and intracellular trafficking [
17,
18]. CD2AP also links podocin and nephrin to the phosphoinositide 3-OH kinase [
19]. TRPC6 functions as a podocyte calcium influx pathway and upstream regulator of podocyte cytoskeleton [
20]. (b) Podocyte cytoskeleton related molecules include α-actinin-4 [
21], inverted formin 2 (
INF2) [
22], and anillin (
ANLN) [
23]. Their mutations impair the integrity of the podocyte actin cytoskeleton [
23‐
25]. Mutated
INF2 is the most common cause of autosomal dominant (AD) FSGS. Recently, mutations in
ARHGDIA [
26] and
ARHGAP24 [
27] and increased expression of podocyte-specific
RAP1GAP [
28] were shown to regulate small GTPases including Rac1 and RAP1, thereby dysregulating the podocyte actin networks. In addition, podocyte endocytosis involving dynamin, synaptojanin, and endophilin proteins is important for the maintenance of the glomerular filtration barrier (GFB) via an action on actin dynamics [
29]. (c) Mutations in podocyte transcription factors
LMX1B and WT-1 cause Nail-patella syndrome [
30,
31] or Denys-Drash/Frasier syndrome [
32] respectively. Moreover, the WT1-R458Q mutation was reported recently as the cause of nonsyndromic AD FSGS [
33]. (d) Mutations in adhesion and extracellular matrix molecules such as integrins and laminin-β2 (
LAMB2) play an important role in the pathogenesis of FSGS. Mutations in
LAMB2 cause Pierson syndrome (OMIM 609049), which is characterized by CNS/diffuse mesangial sclerosis, severe ocular abnormalities, and neurodevelopmental impairments [
34‐
36]. Laminin, type IV collagen, nidogen, and sulfated proteoglycans comprise the GBM [
37], and laminins are heterotrimeric glycoproteins containing one α, one β, and one γ chain. The major laminin heterotrimer in the mature GBM is laminin α5β2γ1, or LM-521 [
38]. Laminin trimerization occurs in the endoplasmic reticulum (ER) and involves association of the three chains along their laminin coiled-coil domains to form the long arm [
39]. Once trimers are secreted into the extracellular space, they polymerize to form the supramolecular laminin network via interactions among the NH2-termini of the short arms (LN domains) [
40,
41].
Lamb2 null mice recapitulate Pierson syndrome [
42‐
47]. Although
LAMB2 null mutations cause the full syndromic phenotype of Pierson syndrome, certain
LAMB2 missense mutations, including R246Q and C321R, which are located in the LN or LEa domain of LAMB2 respectively, cause CNS with mild extrarenal features [
48]. Using our established cell and knockout/transgenic mouse models resembling human NS harboring the R246Q or C321R mutation respectively, we have shown that both R246Q and C321R mutations cause defective secretion of laminin-521 from podocytes to the GBM [
49,
50]. Furthermore, we have demonstrated that the misfolded C321R mutant protein induces podocyte ER stress and proteinuria
in vivo [
50].
Besides the direct disease-causing gene mutations in FSGS, the role of genetic risk variants in FSGS has also been investigated. A classic example is apolipoprotein L1 (
APOL1) gene risk variants-associated nephropathy [
54], which is a devastating spectrum of kidney diseases including focal global glomerulosclerosis (FGGS) that was historically attributed to hypertension, FSGS or the collapsing variant, sickle cell nephropathy, and severe lupus nephritis in AAs. The risk variants G1 (S342G:I384M) and G2 (del.N388/Y389) are two coding variants in the
APOL1 gene on chromosome 22q13. The mutant alleles confer protection against trypanosomal infections in AAs at the cost of an increased risk of kidney disease. Although 51 % of AAs have at least one risk allele and 13 % have two parental risk alleles, only a subset of individuals with genetic risk develops kidney disease. It is likely that the interplay between
APOL1 and several modifiable environmental factors or interactive genes such as
NPHS2,
SDCCAG8, and
BMP4 produces the variable spectrum of
APOL1 nephropathy [
55].